DYDC2 Antibody (04) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06212IR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 04
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human DYDC2 (Uniprot#: Q96IM9; Thr102-Pro176).
Reactivity Notes
No cross-reactivity in ELISA with:
Insect cell lysate
Insect cell lysate
Specificity
No cross-reactivity in ELISA with: Insect cell lysate
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for DYDC2 Antibody (04) [DyLight 755]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: DYDC2
Alternate Names
bA36D19.6, DPY30 domain containing 2, DPY30 domain-containing protein 2, MGC16186
Gene Symbol
DYDC2
Additional DYDC2 Products
Product Documents for DYDC2 Antibody (04) [DyLight 755]
Product Specific Notices for DYDC2 Antibody (04) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...